Systems and methods for concurrent multi-frequency impedance measurements to characterize a substance of interest (e.g., analyte concentration) are disclosed herein. Generally, in some variations a method for characterizing a substance includes generating an input signal having a first set of frequency components across a plurality of frequencies, exciting an electrode arrangement with the input signal wherein the electrode arrangement is in contact with the substance. receiving an output signal from the excited electrode arrangement, the output signal having a second set of frequency components across the plurality of frequencies, determining an impedance signature of the substance across the plurality of frequencies, based on the first and second sets of frequency components, and characterizing the substance based on the impedance signature.
A system for a physiological characteristic sensor deployed with a sensor inserter includes an adhesive skin patch coupled to the physiological characteristic sensor. The adhesive patch is to couple the physiological characteristic sensor to an anatomy. The system also includes a gravity resistance system coupled to the adhesive patch and to be coupled to the sensor inserter. The gravity resistance system maintains the adhesive patch substantially perpendicular to a longitudinal axis of the sensor inserter prior to deployment of the physiological characteristic sensor and is removable from the adhesive patch by the sensor inserter upon deployment of the physiological characteristic sensor.
Techniques for automatic device configuration are disclosed herein. In some embodiments, the techniques involve receiving patient data by one or more processors of a cloud-based server device. The techniques further involve obtaining, by the cloud-based server device, and based on the patient data, a value of a total daily dose of insulin for the specific patient. The techniques further involve automatically selecting, by the cloud-based server device, before the medical device has been set up to deliver insulin to the specific patient, a therapy configuration for the medical device. The techniques further involve determining, by the cloud-based server device, a set of therapy settings for the selected therapy configuration for the specific patient based upon the value of the total daily dose. The techniques further involve automatically configuring, via a non-medical device, the medical device with the set of therapy settings in a startup mode.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
09 - Scientific and electric apparatus and instruments
Goods & Services
Downloadable and mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and diabetes patient data; downloadable and mobile applications used to operate, monitor and manage diabetes medical devices, insulin pumps and glucose monitors; downloadable and mobile applications used for the monitoring and treatment of diabetes; downloadable computer application software for mobile devices, namely, software for accessing a diabetes patient's medical and physiological data
09 - Scientific and electric apparatus and instruments
Goods & Services
Downloadable and recorded computer software and downloadable mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and patient data; downloadable and recorded computer software and downloadable mobile applications used to operate, monitor and manage medical devices, insulin pumps and glucose monitors; downloadable and recorded computer software and downloadable mobile applications used for the monitoring and treatment of diabetes.
6.
MODELING TARGETS OF CONTINUOUS GLUCOSE MONITORING METRICS FOR GLYCEMIC CONTROL
Disclosed herein are techniques for blood glucose management. In one example, a processor-implemented method includes receiving an input of a target value of a first continuous glucose monitoring (CGM) metric, estimating a target value of at least a second CGM metric that corresponds to the target value of the first CGM metric, and providing the estimated target value of at least the second CGM metric to a user. In some examples, the processor-implemented method also includes determining that the estimated target value of at least the second CGM metric meets a predetermined criterion, and configuring an insulin delivery system based on the target value of the first CGM metric.
A linear voltage regulator is disclosed. The voltage regulator is configured and controlled such that its output current is substantially equal to the input current. A method for measuring electrical current consumption of a device under test (DUT) is disclosed. The test system comprises a power capacitor, a voltage regulator, and a switching circuit. The method may involve: controlling the switching circuit to switch the test system from a first state to a measurement state such that the power capacitor provides the capacitor voltage to the voltage regulator; detecting that loading by the DUT has caused the voltage of the power capacitor to drop below a threshold; and determining the electrical current consumed by the DUT based on the electrical current provided by the power capacitor in a time period corresponding to a duration of the measurement state.
G05F 1/575 - Regulating voltage or current wherein the variable actually regulated by the final control device is DC using semiconductor devices in series with the load as final control devices characterised by the feedback circuit
G01R 1/28 - Provision in measuring instruments for reference values, e.g. standard voltage, standard waveform
8.
AMBULATORY INFUSION PUMPS AND ASSEMBLIES FOR USE WITH SAME
Ambulatory infusion pumps, medicament reservoirs, and medicament sealing assemblies, including a variety of trocar seal assemblies and fill plug seal assemblies, plus related components, as well as component combinations and related methods.
A method of testing one or more analyte sensors each comprising a first electrode; a second electrode; and a material layer disposed on or above the first electrode; the method including (a) applying a voltage potential to the first electrode with respect to the second electrode; (b) measuring a test signal comprising an output current from the first electrode that results from the application of the voltage potential; (c) using the test signal from (b) to observe an electrical characteristic of the analyte sensor; and (d) correlating the electrical characteristic a parameter associated with an electrochemical response of the analyte sensor to an analyte, wherein the testing is under dry conditions without exposure of the electrodes to a fluid containing the analyte or an in-vivo environment containing the analyte.
A61B 5/1468 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
G01N 27/02 - Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance
G01N 27/26 - Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variablesInvestigating or analysing materials by the use of electric, electrochemical, or magnetic means by using electrolysis or electrophoresis
According to an aspect, a cannula insertion mechanism includes a seal and a cannula carrier. The seal is configured to surround an opening of a housing, the seal including a first seal surface and a second seal surface, the first seal surface facing toward the opening, and the second seal surface facing away from the opening. The cannula carrier is configured to drive a cannula in a first direction through the opening of the housing, the cannula carrier having a first carrier surface and a second carrier surface, the first carrier surface being configured to exert a compression force on the second seal surface when the cannula carrier drives the cannula in the first direction, thereby causing the first seal surface to expand in a second direction to engage the second carrier surface via a clamping force.
A method for optional external calibration of a calibration-free glucose sensor uses values of measured working electrode current (Isig) and EIS data to calculate a final sensor glucose (SG) value. Counter electrode voltage (Vcntr) may also be used as an input. Raw Isig and Vcntr values may be preprocessed, and low-pass filtering, averaging, and/or feature generation may be applied. SG values may be generated using one or more models for predicting SG calculations. When an external blood glucose (BG) value is available, the BG value may also be used in calculating the SG values. A SG variance estimate may be calculated for each predicted SG value and modulated, with the modulated SG values then fused to generate a fused SG. A Kalman filter, as well as error detection logic, may be applied to the fused SG value to obtain a final SG, which is then displayed to the user.
A61B 5/1495 - Calibrating or testing in vivo probes
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/0537 - Measuring body composition by impedance, e.g. tissue hydration or fat content
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
The present disclosure relates to the use of a PFAS-free cannula in delivering a fluid medication, such as insulin, to a subcutaneous site. The cannula comprises polycarbonate polyurethane polysiloxane (PC-PU-PS), wherein the cannula is configured for subcutaneous insertion into the tissue of the individual in need thereof. The disclosure includes methods for administering insulin using the cannula and infusion devices comprising the cannula.
Systems and methods for mitigating backflow in subcutaneous infusion devices are disclosed. A medical device can include base having a surface configured to be placed against a patient's skin and a subcutaneous assembly coupled to the base and configured to be inserted through the patient's skin when the surface of the base is placed against the patient's skin. The subcutaneous assembly includes an infusion cannula defining a lumen extending therethrough and configured to infuse fluid therethrough, and a sensor configured to sense a biological analyte. An expandable member (e.g., a swellable material) is coupled to a radially outer surface of the subcutaneous assembly. The expandable member is configured to expand in a radially outward direction when in the presence of bodily fluid, thereby at least partially blocking a flow path from the distal end portion of the infusion cannula to the sensor.
The present disclosure relates to a self-lubricating cannula for use in delivering a fluid medication to a subcutaneous site. The self-lubricating cannula comprises polyether block polyamide and an additive configured to facilitate the manufacture of a tipped self-lubricating cannula. The present disclosure also provides a method of making a self-lubricating cannula and a method of administering insulin using a self-lubricating cannula.
09 - Scientific and electric apparatus and instruments
Goods & Services
Downloadable and recorded computer software and downloadable mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and patient data; downloadable and recorded computer software and downloadable mobile applications used to operate, monitor and manage medical devices, insulin pumps and glucose monitors; downloadable and recorded computer software and downloadable mobile applications used for the monitoring and treatment of diabetes
09 - Scientific and electric apparatus and instruments
Goods & Services
Downloadable and recorded computer software and downloadable mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and patient data; downloadable and recorded computer software and downloadable mobile applications used to operate, monitor and manage medical devices, insulin pumps and glucose monitors; downloadable and recorded computer software and downloadable mobile applications used for the monitoring and treatment of diabetes
Techniques disclosed herein relate to adjustable glucose sensor initialization sequences. In some embodiments, the techniques may involve determining an initial amplitude of one or more voltage pulses of a sequence of voltage pulses applied to a working electrode of the glucose sensor that is at least partially inserted subcutaneously in a patient. The techniques may further involve determining a slope of one or more parameters of the glucose sensor. The techniques may further involve determining an updated amplitude of the one or more voltage pulses based on the slope of the one or more parameters. The techniques may further involve executing an initialization sequence using the one or more voltage pulses having the updated amplitude to the working electrode of the glucose sensor.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1468 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means
18.
STRUCTURALLY REINFORCED SENSOR AND METHOD FOR MANUFACTURING THE SAME
A sensor having a distal end and an intermediate region adjacent to the distal end is provided. The sensor includes an insulator base substrate, sensor electrodes over the insulator base substrate, an electrode lead pattern over the insulator base substrate, wherein the electrode lead pattern includes electrode leads configured for contact with the sensor electrodes, and wherein the electrode leads extend completely across the intermediate region in a longitudinal direction, and a structural backing layer over the electrode lead pattern and insulator base substrate; wherein a side edge of the structural backing layer over the electrode lead pattern extends completely across the structural backing layer in the longitudinal direction.
Methods, systems, and devices are disclosed for administering a medicament to a patient. In one aspect, a system includes an injection pen device in wireless communication with a mobile communication device. The injection pen device includes a housing including a chamber to encase a cartridge containing medicine, a dose setting and dispensing mechanism to set the mechanism to dispense a particular dose of the medicine from the loaded cartridge, a sensor unit to detect a dispensed dose based on positions and/or movements of the dose setting and dispensing mechanism, and an electronics unit in communication with the sensor unit to process the detected dispensed dose and time data associated with a dispensing event and to wirelessly transmit the dose data to a user's device. The mobile communication device provides a software application to provide the user with health information using the processed dose data.
A61M 5/315 - PistonsPiston-rodsGuiding, blocking or restricting the movement of the rodAppliances on the rod for facilitating dosing
G16H 20/13 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
Methods and devices are provided for reducing a diabetic patient's foreign body immune response, including infusion site-loss and/or occlusion. Such foreign body responses are associated with the treatment of the diabetic patient where the treatment requires subcutaneous implantation of a foreign body, such as a cannula or catheter. In certain embodiments of the invention, a response-inhibiting agent is administered to a patient at the site of cannula/catheter insertion, thereby facilitating delivery of insulin to the diabetic patient and mitigating site-loss and/or occlusion over a period of time.
Systems and methods are described herein for utilizing a photoacoustic sensor for estimating analyte concentration levels. Also described here are calibration and training methods for calibrating and/or training an analyte sensor to more accurately estimate an analyte concentration level on the basis of a received acoustic signal.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/1455 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using optical sensors, e.g. spectral photometrical oximeters
Techniques disclosed herein relate to managing operations of a dual-mode insulin delivery device that can operate in a manual insulin delivery mode and an automated closed-loop insulin delivery mode. In one example, a processor-implemented method includes obtaining insulin delivery data of an insulin delivery device collected while the insulin delivery device operates in a closed-loop mode, determining an updated value of a parameter of the insulin delivery device in a manual mode based on the insulin delivery data, and causing the insulin delivery device to deliver insulin in the manual mode based on the updated value of the parameter of the insulin delivery device, where the parameter of the insulin delivery device has separate values in the manual mode and the closed-loop mode.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
23.
MULTI-SENSOR GESTURE-BASED OPERATION OF A MEDICATION DELIVERY SYSTEM
Gesture-informed patient management systems and related medical devices and operating methods are provided. A method of operating a medical device capable of influencing a physiological condition of a patient involves obtaining first sensor measurement data from a sensing arrangement associated with a first location on a body of the patient and capable of detecting physical movement by the patient, obtaining second sensor measurement data from a second sensing arrangement having a second location different from the first location, predicting an occurrence of an event based at least in part on the first sensor measurement data in a manner that is influenced by the second sensor measurement data, resulting in a predicted occurrence of the event, and automatically configuring operation of the medical device to influence the physiological condition of the patient in a manner that is influenced by the predicted occurrence of the event.
Removable devices wearable on a user's skin and methods for using such devices are provided. An exemplary removable device includes a skin adhesive configured to adhere to the skin, a durable component, and an interface component interconnecting the durable component and the skin adhesive. The device separates at the interface component to remove the durable component from the skin adhesive upon application of a removal force to the device.
Systems and methods for optically sensing medicament concentrations within medicament delivery devices are disclosed. A medicament delivery device can include a fluid path comprising a reservoir in fluid communication with an outlet port, in which the device is actuatable to drive fluid through the fluid path, from the reservoir and out of the outlet port. A sensor assembly of the delivery device is configured to determine concentration of an analyte in the fluid. The sensor assembly includes an optical emitter configured to emit photons towards a fluid sample within the fluid path, an optical detector configured to receive photons passed through and/or reflected from the fluid sample and provide a detector signal, and one or more signal processing components configured to receive the detector signal and, based at least in part on the detector signal, provide an indication of the analyte concentration in the fluid sample.
Techniques disclosed herein relate to continuous analyte sensor measurements. In some embodiments, the techniques may involve determining that sensor-generated values indicative of a glucose level of a patient are or are to be inhibited when in a first mode. The techniques may further involve responsive to determining that the sensor-generated values are or are to be inhibited, switching operation of an infusion device from the first mode to a second mode. The techniques may further involve obtaining a blood glucose reading from the patient. The techniques may further involve responsive to obtaining the blood glucose reading, reverting operation of the infusion device to the first mode.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
27.
MEDICAL DEVICE CONFIGURATION PROCEDURE GUIDANCE RESPONSIVE TO DETECTED GESTURES
Techniques disclosed herein relate generally to providing guidance for operating (e.g., configuring) a medical device to a user. In some examples, the techniques involve determining, from a pre-defined sequence of tasks for operating a medical device, one or more tasks that have been performed by a user of the medical device; identifying, based on the pre-defined sequence of tasks and the determined one or more tasks, a subsequent task of the pre-defined sequence of tasks for operating the medical device; and generating guidance information for performing the subsequent task of the pre-defined sequence of tasks.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G06F 3/01 - Input arrangements or combined input and output arrangements for interaction between user and computer
G06F 3/048 - Interaction techniques based on graphical user interfaces [GUI]
G16H 40/40 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the management of medical equipment or devices, e.g. scheduling maintenance or upgrades
28.
GLUCOSE LEVEL MANAGEMENT BASED ON FAT CONTENT OF MEALS
Techniques for glucose level management are disclosed. In some examples, the techniques may involve obtaining a macronutrient content associated with a meal, wherein the macronutrient content includes a first macronutrient and a second macronutrient. The techniques may further involve predicting, using a patient-specific physiological simulator that utilizes the macronutrient content, glucose amounts to be absorbed into a bloodstream of a patient as a result of consumption of the meal, wherein the patient-specific physiological simulator is configured to account for a difference in glucose level rise due to consumption of the first macronutrient compared to consumption of the second macronutrient. The techniques may further involve determining, using the patient-specific physiological simulator, a dosage of insulin to deliver to the patient based on the glucose amounts to be absorbed into the bloodstream.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
29.
PERSONALIZED CLOSED LOOP OPTIMIZATION SYSTEMS AND METHODS
Techniques disclosed herein involve automatically adjusting a control parameter for an operating mode of a medical device. In some embodiments, the techniques involve determining a value for the control parameter using data pertaining to a physiological condition of a patient by disproportionately penalizing a physiological parameter when it is below a target range in comparison to when the physiological parameter is above the target range.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 10/40 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
G16H 20/10 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
30.
METHOD AND APPARATUS FOR TRACKING OF FOOD INTAKE AND OTHER BEHAVIORS AND PROVIDING RELEVANT FEEDBACK
Techniques disclosed herein relate generally to monitoring and tracking food intake events or other behaviors. In some examples, the techniques involve detecting, based on at least one of user input or sensor input from a first set of one or more sensors, a start of a food intake event; activating, in response to detecting the start of the food intake event, a second set of one or more sensors for tracking the food intake event; and determining, based on at least sensor data from the second set of one or more sensors, one or more event-specific parameters for the food intake event.
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/11 - Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb
A61B 5/16 - Devices for psychotechnicsTesting reaction times
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
G16H 70/60 - ICT specially adapted for the handling or processing of medical references relating to pathologies
31.
PREDICTION BASED DELIVERING OR GUIDING OF THERAPY FOR DIABETES
Disclosed herein are techniques for prediction based delivering or guiding of therapy for diabetes. In some embodiments, the techniques may involve predicting that a meal event is to occur. The techniques may further involve in response to predicting that the meal event is to occur, determining a partial therapy dosage to be delivered prior to the meal event occurring. The techniques may further involve determining, after a duration of time subsequent to delivery of the partial therapy dosage has elapsed, that meal consumption has not yet begun. The techniques may further involve prompting a patient to begin consumption of the meal.
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G06F 3/01 - Input arrangements or combined input and output arrangements for interaction between user and computer
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
H04M 1/72454 - User interfaces specially adapted for cordless or mobile telephones with means for adapting the functionality of the device according to specific conditions according to context-related or environment-related conditions
H04M 1/72463 - User interfaces specially adapted for cordless or mobile telephones with means for adapting the functionality of the device according to specific conditions to restrict the functionality of the device
Disclosed herein are techniques for regulatory approval submission and review. In some embodiments, a regulatory approval submission and review system includes a repository configured to store a set of regulatory approval submission data and associated metadata for a medical product of a supplier, and a portal communicatively coupled to the repository and configured to filter the set of regulatory approval submission data and the associated metadata in the repository based on the associated metadata and users' roles to provide user specific data and metadata to users of the supplier and users of a regulatory agency.
An analyte sensor configured to compensate for insulin interference includes: a working electrode, including an analyte sensing molecule disposed on the working electrode configured to generate a signal when exposed to an analyte; a processor; and a memory. The memory includes instructions which, when executed by the processor, cause the sensor to: obtain an indication from the pump that the bolus is delivered; in response to the delivery of the bolus, determine at least one of a first electrochemical impedance spectroscopy (EIS) parameter value or a first conductivity value in response to exposure of the working electrode to the analyte; and determine a presence of one or more interferents based on at least one of the first EIS parameter value or the first conductivity value.
Disclosed herein are techniques for regulatory approval submission and review. In some embodiments, a regulatory approval submission and review system includes a repository and a portal. The portal is configured to provide a first user interface for submitting and updating a common set of regulatory approval submission data for a medical product by a submitter, store the common set of regulatory approval submission data to a repository, provide a second user interface for reviewing and providing feedback on the common set of regulatory approval submission data by a regulatory agency, and control access to respective subsets of the common set of regulatory approval submission data by the submitter and the regulatory agency.
A multi-electrode sensor array includes a first electrode configured for sensing a first analyte, and a second electrode configured for sensing a second analyte. The first electrode includes a first electrical connection pad on a first end portion of the first electrode, and a first enzyme on a second portion of the first electrode, the first enzyme configured for sensing the first analyte. The second electrode includes a second electrical connection pad on a first end portion of the second electrode, and a second enzyme on a second portion of the second electrode, the second enzyme configured for sensing the second analyte.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
36.
GLUCOSE LEVEL MANAGEMENT BASED ON PROTEIN CONTENT OF MEALS
Techniques for glucose level management are disclosed. In some examples, the techniques may involve obtaining an estimated value of a first nutrient for a meal and an estimated value of a second nutrient for the meal. The techniques may further involve obtaining a patient-specific conversion factor that predicts a glucose level rise for a patient due to consumption of the first nutrient. The techniques may further involve converting the estimated value of the first nutrient into a corresponding value associated with the second nutrient using the patient-specific conversion factor to generate a conversion of the first nutrient. The techniques may further involve determining an equivalent value associated with the second nutrient for the meal based on the estimated value of the second nutrient and the conversion of the first nutrient.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
Embodiments of the invention provide amperometric analyte sensors having optimized elements such as dexamethasone rejection membranes as well as methods for making and using such sensors. The amperometric analyte sensor apparatus comprises: a base layer; a conductive layer disposed on the base layer and comprising a working electrode; an dexamethasone rejection membrane disposed over an electroactive surface of the working electrode, wherein the interference rejection membrane comprises a poly Hema composition and an analyte sensing layer. While embodiments of the innovation can be used in a variety of contexts, typical embodiments of the invention include glucose sensors used in the management of diabetes.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
38.
PERSONALIZED EVENT DETECTION METHODS AND RELATED DEVICES AND SYSTEMS
Techniques for detection of occurrence of a meal are provided. In some embodiments, the techniques may involve obtaining a plurality of glucose measurements indicative of a glucose level in a body of a patient during an analysis interval. The techniques may further involve detecting an occurrence of a meal during the analysis interval based on the plurality of glucose measurements obtained during the analysis interval. The techniques may further involve updating a user interface to include an indication of the meal detected during the analysis interval.
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G06N 7/01 - Probabilistic graphical models, e.g. probabilistic networks
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
39.
INFUSION DEVICES AND RELATED RESCUE DETECTION METHODS
Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device to deliver fluid to a body of a user involves obtaining measurement values for a physiological condition influenced by the fluid, autonomously operating the infusion device to deliver the fluid based at least in part on the measurement values, and detecting a nonactionable condition based on the measurement values. In response to detecting the nonactionable condition, delivery of the fluid is limited while maintaining autonomous operation of the infusion device. In one exemplary embodiment, the nonactionable condition is a rescue condition indicative of the user having consumed fast-acting carbohydrates, and thus insulin delivery may be automatically limited in response to detecting the rescue carbohydrate consumption.
Systems, devices, and techniques are disclosed for differentiating a therapeutic dose and a priming event to properly administer medication to patients. In one example aspect, a method for differentiating therapeutic doses and priming events in administering a medication to a patient includes determining a time window for monitoring dispensing of the medication by an injection pen device. Multiple dispense events each releasing an amount of the medication occur in the time window. The method also includes classifying dispense events prior to a last dispense event in the time window as priming events or therapeutic doses and designating the last dispense event in the time window as a therapeutic dose for facilitating calculation and tracking of a dosage amount for the patient.
G16H 20/13 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
41.
OVERTAPE DESIGNS FOR DEVICES SUCH AS GLUCOSE SENSORS
Embodiments of the invention provide skin adhesive patches designed to ease a diabetic patient's maneuverability and alignment of a glucose sensing device as the patient adheres the device to their skin. Embodiments of the invention can be adapted for use with a wide variety of medical components that are coupled to the skin of patients, including insulin infusion sets, patch pumps, and all-in-one patch sets.
Fluid reservoir systems are disclosed herein. According to some embodiments, the present technology includes a reservoir defining a cavity and a plunger slidably received within the cavity. The plunger includes a vial interface, a plunger rod extending distally from the vial interface, and a needle extending longitudinally through the plunger rod. The needle has an inlet end at the vial interface and an outlet end proximate a distal portion of the plunger rod. When an outlet end of a vial of fluid medication is coupled to the vial interface, the needle extends through a septum of the vial such that the inlet end of the needle is disposed within the vial. When the plunger is fluidly coupled to the vial, proximal movement of the plunger and vial relative to the reservoir draws the fluid medication out of the vial, through the needle, and into the interior region of the reservoir.
Filters for use with fluid infusion devices are disclosed herein. According to some embodiments, the present technology includes a system for delivering a fluid medication to a patient at an infusion site, the system comprising a fluid conduit configured to transport a fluid medication along at least a portion of a fluid path extending between a reservoir containing the fluid medication and a cannula subcutaneously inserted in a patient at an infusion site, and a filter disposed within the fluid conduit and configured to trap particulates that form in the fluid medication, wherein the filter comprises a porous structure including glycerin.
Techniques related to temporary setpoint values are disclosed. The techniques may involve causing operation of a fluid delivery device in a closed-loop mode for automatically delivering fluid based on a difference between a first setpoint value and an analyte concentration value during operation of the fluid delivery device in the closed-loop mode. Additionally, the techniques may involve obtaining a second setpoint value. The second setpoint value may be a temporary setpoint value to be used for a period of time to regulate fluid delivery, and the second setpoint value may be greater than the first setpoint value. The techniques may further involve causing operation of the fluid delivery device for automatically reducing fluid delivery for the period of time based on the second setpoint value.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16Z 99/00 - Subject matter not provided for in other main groups of this subclass
Medical apparatus for use in monitoring and treatment of diabetes, comprised of infusion pumps, programmers, glucose monitors, glucose strip meters, and programming software and software algorithms sold as an integral component for use in operating such apparatus.
09 - Scientific and electric apparatus and instruments
10 - Medical apparatus and instruments
Goods & Services
Downloadable mobile application software for mobile devices used to display, manage, monitor, and track blood glucose and insulin for use in diabetes; downloadable and recorded computer software used to operate and manage diabetes and blood glucose medical devices. Devices for monitoring blood glucose for medical purposes; insulin pumps; insulin injectors; insulin pens consisting of insulin injectors, blood glucose sensors, and insulin monitors; medical apparatuses, namely, insulin delivery systems comprised of glucose monitors, insulin monitors, infusion sets, and infusion reservoirs sold as a unit and used to display, manage, monitor, and track blood glucose and insulin for use in diabetes patient management.
09 - Scientific and electric apparatus and instruments
Goods & Services
Downloadable and mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and diabetes patient data; downloadable and mobile applications used to operate, monitor and manage diabetes medical devices, insulin pumps and glucose monitors; downloadable and mobile applications used for the monitoring and treatment of diabetes; downloadable computer application software for mobile devices, namely, software for accessing a diabetes patient's medical and physiological data.
48.
INFUSION DEVICES AND RELATED METHODS AND SYSTEMS FOR PREEMPTIVE ALERTING
Techniques disclosed herein relate to infusion devices and alerts. In some embodiments, the techniques may involve determining an expected glucose measurement value after delivery of a correction bolus based on an amount of the correction bolus and a current amount of active insulin in a body of a patient. The techniques may further involve obtaining a current glucose measurement value. The techniques may further involve detecting an anomalous response to the correction bolus responsive to determining that a difference between the current glucose measurement value and the expected glucose measurement value exceeds a predetermined threshold.
A61M 5/168 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
09 - Scientific and electric apparatus and instruments
10 - Medical apparatus and instruments
41 - Education, entertainment, sporting and cultural services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Downloadable and recorded computer software and downloadable
mobile applications used to measure, collect, transmit,
monitor, track and analyze diabetes information and patient
data; downloadable and recorded computer software and
downloadable mobile applications used to operate, monitor
and manage medical devices, insulin pumps and glucose
monitors; downloadable and recorded computer software and
downloadable mobile applications used for the monitoring and
treatment of diabetes; computer hardware and peripherals for
use in the medical field; downloadable electronic
publications in the nature of books, manuals, articles,
newsletters and brochures in the field of detection,
monitoring and treatment of diabetes and the use of medical
devices used to detect, monitor and treat diabetes. Medical devices used for the treatment of diabetes; medical
apparatus for diabetes, namely, blood glucose monitors;
medical equipment, namely, instruments and sensors for
measuring blood glucose levels and instruments and sensors
for diabetes monitoring; infusion apparatus for therapeutic
purposes; injection device for pharmaceuticals; medical test
kits for diabetes monitoring for home use. Providing courses of instruction in the field of detection,
monitoring and treatment of diabetes and the use of medical
devices used to detect, monitor and treat diabetes;
providing online non-downloadable electronic publications in
the nature of books, manuals, articles, newsletters and
brochures in the field of detection, monitoring and
treatment of diabetes and the use of medical devices used to
detect, monitor and treat diabetes. Providing temporary use of non-downloadable computer
software used for the detection, monitoring, management, and
treatment of diabetes; providing temporary use of
non-downloadable computer software used to operate, monitor
and manage medical devices, insulin pumps and glucose
monitors. Providing medical information; providing medical information
via a website; providing medical information in the field of
detection, monitoring and treatment of diabetes and the use
of medical devices used to detect, monitor and treat
diabetes.
09 - Scientific and electric apparatus and instruments
10 - Medical apparatus and instruments
41 - Education, entertainment, sporting and cultural services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Downloadable and recorded computer software and downloadable
mobile applications used to measure, collect, transmit,
monitor, track and analyze diabetes information and patient
data; downloadable and recorded computer software and
downloadable mobile applications used to operate, monitor
and manage medical devices, insulin pumps and glucose
monitors; downloadable and recorded computer software and
downloadable mobile applications used for the monitoring and
treatment of diabetes; computer hardware and peripherals for
use in the medical field; downloadable electronic
publications in the nature of books, manuals, articles,
newsletters and brochures in the field of detection,
monitoring and treatment of diabetes and the use of medical
devices used to detect, monitor and treat diabetes. Medical devices used for the treatment of diabetes; medical
apparatus for diabetes, namely, blood glucose monitors;
medical equipment, namely, instruments and sensors for
measuring blood glucose levels and instruments and sensors
for diabetes monitoring; infusion apparatus for therapeutic
purposes; injection device for pharmaceuticals; medical test
kits for diabetes monitoring for home use. Providing courses of instruction in the field of detection,
monitoring and treatment of diabetes and the use of medical
devices used to detect, monitor and treat diabetes;
providing online non-downloadable electronic publications in
the nature of books, manuals, articles, newsletters and
brochures in the field of detection, monitoring and
treatment of diabetes and the use of medical devices used to
detect, monitor and treat diabetes. Providing temporary use of non-downloadable computer
software used for the detection, monitoring, management, and
treatment of diabetes; providing temporary use of
non-downloadable computer software used to operate, monitor
and manage medical devices, insulin pumps and glucose
monitors. Providing medical information; providing medical information
via a website; providing medical information in the field of
detection, monitoring and treatment of diabetes and the use
of medical devices used to detect, monitor and treat
diabetes.
09 - Scientific and electric apparatus and instruments
10 - Medical apparatus and instruments
41 - Education, entertainment, sporting and cultural services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Downloadable and recorded computer software and downloadable
mobile applications used to measure, collect, transmit,
monitor, track and analyze diabetes information and patient
data; downloadable and recorded computer software and
downloadable mobile applications used to operate, monitor
and manage medical devices, insulin pumps and glucose
monitors; downloadable and recorded computer software and
downloadable mobile applications used for the monitoring and
treatment of diabetes; computer hardware and peripherals for
use in the medical field; downloadable electronic
publications in the nature of books, manuals, articles,
newsletters and brochures in the field of detection,
monitoring and treatment of diabetes and the use of medical
devices used to detect, monitor and treat diabetes. Medical devices used for the treatment of diabetes; medical
apparatus for diabetes, namely, blood glucose monitors;
medical equipment, namely, instruments and sensors for
measuring blood glucose levels and instruments and sensors
for diabetes monitoring; infusion apparatus for therapeutic
purposes; injection device for pharmaceuticals; medical test
kits for diabetes monitoring for home use. Providing courses of instruction in the field of detection,
monitoring and treatment of diabetes and the use of medical
devices used to detect, monitor and treat diabetes;
providing online non-downloadable electronic publications in
the nature of books, manuals, articles, newsletters and
brochures in the field of detection, monitoring and
treatment of diabetes and the use of medical devices used to
detect, monitor and treat diabetes. Providing temporary use of non-downloadable computer
software used for the detection, monitoring, management, and
treatment of diabetes; providing temporary use of
non-downloadable computer software used to operate, monitor
and manage medical devices, insulin pumps and glucose
monitors. Providing medical information; providing medical information
via a website; providing medical information in the field of
detection, monitoring and treatment of diabetes and the use
of medical devices used to detect, monitor and treat
diabetes.
Disclosed herein are techniques related to dynamic forecasts. The techniques may involve obtaining, from a medical device, measurement data for a patient; forecasting a plurality of values for a condition of the patient based on a forecasting model and the obtained measurement data; providing a graphical user interface depicting the plurality of forecasted values and comprising a plurality of adjustable graphical user interface elements, each associated with a time period and an activity or event likely to influence the condition; obtaining an adjustment to a first adjustable graphical user interface element; in response to obtaining the adjustment to the first adjustable graphical user interface element, updating at least one of the forecasted values based on the adjustment to the first adjustable graphical user interface element, the obtained measurement data, and the forecasting model; and dynamically updating the graphical user interface to reflect the updated at least one forecasted value.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
In general, the disclosure describes techniques for generating sounds in fully sealed medical devices. The example techniques for generating sounds in medical devices include the use of a plurality of sound chambers arranged in a stacked configuration that propagate the sound, along with one or more diaphragms configured to vibrate in response to the sound propagating through the medical device. In one or more examples, an external housing that includes an overlay cover may fully enclose the medical device, where the overlay cover (e.g., the entire overlay cover or a part of the overlay cover) also vibrates to propagate the sound out of the medical device.
09 - Scientific and electric apparatus and instruments
10 - Medical apparatus and instruments
Goods & Services
Downloadable mobile application software for mobile devices used to display, manage, monitor, and track blood glucose and insulin for use in diabetes Devices for monitoring blood glucose for medical purposes; insulin pumps; insulin injectors; insulin pens consisting of insulin injectors, blood glucose sensors, and insulin monitors; medical apparatuses, namely, insulin delivery systems comprised of glucose monitors, insulin monitors, infusion sets, and infusion reservoirs sold as a unit and used to display, manage, monitor, and track blood glucose and insulin for use in diabetes patient management
55.
SYNERGISTIC FEATURES AND FUNCTIONS RELATED TO OPERATION OF A MEDICATION DELIVERY SYSTEM AND A MEAL TRANSACTION APPLICATION
The subject matter of this disclosure generally relates to a medical device system and related methodologies that leverage data associated with the use of a meal transaction application, such as an application for ordering food delivery. Data generated by the meal transaction application can be leveraged by a patient care system or application for purposes of diet or calorie logging. Alternatively or additionally, the meal transaction data can be leveraged for purposes of controlling the administration of therapy by a medication delivery system, such as an insulin infusion pump.
medical apparatus for use in monitoring and treatment of diabetes, comprised of infusion pumps, programmers, glucose monitors, glucose strip meters, and programming software and software algorithms sold as an integral component for use in operating such apparatus
57.
ENERGY MANAGEMENT BASED ON AN OPEN SWITCH CONFIGURATION
A sensor assembly for sensing a physiological characteristic includes a housing, and a power source and a power control switch within the housing. The power control switch is electrically coupled to the power source, and is configured to inhibit delivery of power to one or more components of the sensor assembly when the sensor assembly is in a pre-deployment state, and maintain the delivery of power to the one or more components of the sensor assembly when the sensor assembly is in a deployed state. In some examples, an output of the power control switch is latched by a power latch upon deployment of the sensor assembly.
A glucose biosensor encasement includes a first membrane and a second membrane. The first membrane has a first interlocking segment. The second membrane has a second interlocking segment cooperating with the first interlocking segment of the first membrane to provide a cavity between the first membrane and the second membrane configured to receive a glucose sensor. At least one of the first membrane and the second membrane comprises a semi-permeable portion configured to regulate diffusion characteristics of glucose through the membrane to realize a sensitivity for a sensor in the cavity. A method is also provided.
A system for reducing sensor variability includes a sensor configured to generate real-time data relating to glucose sensitivity. The system causes performance of accessing the real-time data from the sensor relating to glucose sensitivity and inputting the real-time data into a machine learning model. The system also causes performance of estimating by the machine learning model an expected glucose sensitivity based on the real-time data and correcting the glucose sensitivity based on the expected glucose sensitivity.
Disclosed herein are techniques related to determining medical parameters. In some embodiments, the techniques involve: obtaining a metric of insulin dosage for a patient; and determining at least one carbohydrate-to-insulin ratio for the patient based at least in part on a model and using the obtained metric of insulin dosage for the patient, wherein parameters of the model were determined based on data associated with a population of patients.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
Embodiments of the invention provide compositions useful in implantable devices such as analyte sensors as well as methods for making and using such compositions and devices. In typical embodiments of the invention, the device is a glucose sensor comprising a polymeric composition disposed on a flexible assembly within the sensor that includes amounts of one or more immunosuppressant agents designed to provide such sensors with improved material properties such as enhanced biocompatibility.
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
62.
DIABETES THERAPY BASED ON DETERMINATION OF FOOD ITEM
Techniques for therapy delivery for diabetes treatment are provided. In some embodiments, the techniques may involve identifying an object as a food item based on a representation of the object. In some embodiments, the techniques may involve generating nutrition information or volume information of the food item. The techniques may involve determining that the nutrition information or the volume information of the food item exceeds a threshold. The techniques may involve determining that the patient's glucose level will rise based on the determination the nutrition information or the volume information of the particular food item exceeds the threshold. The techniques may involve generating therapy information for a patient based on the determination that the patient's glucose level will rise. The techniques may involve automatically administering insulin to the patient to cause the glucose level of the patient to lower to within a predetermined range and based on the therapy information.
G16H 20/60 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
09 - Scientific and electric apparatus and instruments
10 - Medical apparatus and instruments
41 - Education, entertainment, sporting and cultural services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Downloadable and recorded computer software and downloadable mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and patient data; downloadable and recorded computer software and downloadable mobile applications used to operate, monitor and manage medical devices, insulin pumps and glucose monitors; downloadable and recorded computer software and downloadable mobile applications used for the monitoring and treatment of diabetes; computer hardware and peripherals for use in the medical field; downloadable electronic publications in the nature of books, manuals, articles, newsletters and brochures in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
(2) Medical devices used for the treatment of diabetes; medical apparatus for diabetes, namely, blood glucose monitors; medical equipment, namely, instruments and sensors for measuring blood glucose levels and instruments and sensors for diabetes monitoring; infusion apparatus for therapeutic purposes; injection device for pharmaceuticals; medical test kits for diabetes monitoring for home use. (1) Providing courses of instruction in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes; providing online non-downloadable electronic publications in the nature of books, manuals, articles, newsletters and brochures in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
(2) Providing temporary use of non-downloadable computer software used for the detection, monitoring, management, and treatment of diabetes; providing temporary use of non-downloadable computer software used to operate, monitor and manage medical devices, insulin pumps and glucose monitors.
(3) Providing medical information; providing medical information via a website; providing medical information in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
09 - Scientific and electric apparatus and instruments
10 - Medical apparatus and instruments
41 - Education, entertainment, sporting and cultural services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Downloadable and recorded computer software and downloadable mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and patient data; downloadable and recorded computer software and downloadable mobile applications used to operate, monitor and manage medical devices, insulin pumps and glucose monitors; downloadable and recorded computer software and downloadable mobile applications used for the monitoring and treatment of diabetes; computer hardware and peripherals for use in the medical field; downloadable electronic publications in the nature of books, manuals, articles, newsletters and brochures in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
(2) Medical devices used for the treatment of diabetes; medical apparatus for diabetes, namely, blood glucose monitors; medical equipment, namely, instruments and sensors for measuring blood glucose levels and instruments and sensors for diabetes monitoring; infusion apparatus for therapeutic purposes; injection device for pharmaceuticals; medical test kits for diabetes monitoring for home use. (1) Providing courses of instruction in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes; providing online non-downloadable electronic publications in the nature of books, manuals, articles, newsletters and brochures in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
(2) Providing temporary use of non-downloadable computer software used for the detection, monitoring, management, and treatment of diabetes; providing temporary use of non-downloadable computer software used to operate, monitor and manage medical devices, insulin pumps and glucose monitors.
(3) Providing medical information; providing medical information via a website; providing medical information in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
09 - Scientific and electric apparatus and instruments
10 - Medical apparatus and instruments
41 - Education, entertainment, sporting and cultural services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Downloadable and recorded computer software and downloadable mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and patient data; downloadable and recorded computer software and downloadable mobile applications used to operate, monitor and manage medical devices, insulin pumps and glucose monitors; downloadable and recorded computer software and downloadable mobile applications used for the monitoring and treatment of diabetes; computer hardware and peripherals for use in the medical field; downloadable electronic publications in the nature of books, manuals, articles, newsletters and brochures in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
(2) Medical devices used for the treatment of diabetes; medical apparatus for diabetes, namely, blood glucose monitors; medical equipment, namely, instruments and sensors for measuring blood glucose levels and instruments and sensors for diabetes monitoring; infusion apparatus for therapeutic purposes; injection device for pharmaceuticals; medical test kits for diabetes monitoring for home use. (1) Providing courses of instruction in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes; providing online non-downloadable electronic publications in the nature of books, manuals, articles, newsletters and brochures in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
(2) Providing temporary use of non-downloadable computer software used for the detection, monitoring, management, and treatment of diabetes; providing temporary use of non-downloadable computer software used to operate, monitor and manage medical devices, insulin pumps and glucose monitors.
(3) Providing medical information; providing medical information via a website; providing medical information in the field of detection, monitoring and treatment of diabetes and the use of medical devices used to detect, monitor and treat diabetes.
66.
SYSTEMS AND METHODS FOR IMPEDIMETRIC GLUCOSE SENSING USING BORONIC ACID VIOLOGEN (OBBV)
An oxygen-independent analyte sensor includes at least one electrode and an oxygen-independent analyte sensing molecule disposed on the at least one electrode. The oxygen-independent analyte sensing molecule is electrografted on to the at least one electrode. The sensor may process an electrochemical impedance spectroscopy (EIS) parameter value in response to exposure to an analyte.
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
Techniques disclosed herein relate to glucose level measurement and/or management. In some embodiments, the techniques involve obtaining in vivo characteristics of a glucose sensor predicted using fabrication process measurement data associated with the glucose sensor, the in vivo characteristics including an in vivo sensitivity, an in vivo intercept, or a combination thereof; receiving sensor measurement data measured by the glucose sensor, the sensor measurement data including sensor current (Isig), counter voltage (Vcntr), electrochemical impedance spectroscopy (EIS) data, an age of the glucose sensor, or a combination thereof; and estimating a sensor glucose (SG) value using an SG model, wherein input parameters of the SG model include the in vivo characteristics of the glucose sensor and the sensor measurement data, and the SG value is an output of the SG model.
A medicine administration and tracking system includes a delivery device configured to deliver a plurality of doses of medicine over a plurality of days and a computing device configured to receive dose information for each dose. The computing device includes a software application operable to cause the computing device to retrieve the dose information for all doses within a pre-determined period of days, categorize each dose within the pre-determined period of days into one of a plurality of time blocks throughout a 24-hour timeframe, determine a time of interest based on a time block of the plurality of time blocks having the least amount of doses categorized therein, and select a physiological parameter reading from a plurality of physiological parameter readings as a physiological parameter reading of interest based on a proximity of a time of the physiological parameter reading to the determined time of interest.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61M 5/20 - Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
G16H 50/70 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
A processor-implemented method includes receiving sensor measurement data from a glucose sensor; selecting, based on the sensor measurement data, a first regional sensor glucose (SG) model from a first plurality of regional SG models for respective regions of a first plurality of regions of an input parameter space associated with the sensor measurement data, and a second regional SG model from a second plurality of regional SG models for respective regions of a second plurality of regions of the input parameter space; estimating a first SG value and a second SG value using the first regional SG model and the second regional SG model, respectively; and determining a predicted SG value based on a combination of the first SG value and the second SG value. The input parameter space is partitioned into the first plurality of regions and the second plurality of regions using different partition schemes.
Techniques disclosed herein relate to automatic association of a non-medical device with a medical device. In some embodiments, the techniques involve pre-storing first identification information of a first device in a second device, receiving second identification information of the first device by the second device from the first device, and establishing a secure communication link between the first device and the second device based on determining by the second device that the second identification information corresponds to the first identification information. At least one of the first device or the second device includes a medical device.
H04L 9/32 - Arrangements for secret or secure communicationsNetwork security protocols including means for verifying the identity or authority of a user of the system
H04L 67/10 - Protocols in which an application is distributed across nodes in the network
H04W 12/03 - Protecting confidentiality, e.g. by encryption
H04W 12/04 - Key management, e.g. using generic bootstrapping architecture [GBA]
An analyte sensor includes a microcontroller, a base layer, a conductive layer disposed on the base layer where the conductive layer includes a working electrode configured to provide a current signal in presence of glucose, an interference rejection membrane (“IRM”) layer disposed on the working electrode where the IRM layer is negatively charged, and an enzyme layer disposed on the IRM layer where the enzyme layer includes an enzyme selected to generate a detectable electrical signal upon exposure to the glucose. The microcontroller is configured to process an electrochemical impedance spectroscopy (EIS) parameter to determine a state of the IRM layer.
Infusion devices are disclosed herein. The present technology includes, for example, an infusion device for delivering a medicament to a body of a user. The device can comprise an insertion assembly comprising a cannula, a reservoir assembly comprising a reservoir configured to receive a medicament, and a trigger assembly configured to trigger insertion of the cannula into the user in response to a command from a remote computing device communicatively coupled to the infusion device.
A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
74.
NUTRITIONAL CONTENT DETERMINATION BASED ON GESTURE DETECTION DATA
Techniques disclosed herein relate to nutritional content determination based on gesture detection data. In some examples, the techniques involve obtaining gesture detection data corresponding to consumption of a food item or a drink, determining nutritional content of the food item or the drink based on the gesture detection data, and causing delivery of insulin in accordance with the nutritional content of the food item or the drink.
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
H04W 4/80 - Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication
75.
CONTEXTUAL PERSONALIZED CLOSED-LOOP ADJUSTMENT METHODS AND SYSTEMS
Techniques for adjustment of control parameters are provided. In some embodiments, the techniques may involve causing fluid delivery to a patient based on a first value for a control parameter. The techniques may further involve determining an anomalous physiological condition of the patient. The techniques may further involve in response to determining the anomalous physiological condition, causing fluid delivery to the patient based on a second value for the control parameter.
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/67 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
A medical device includes a sensor to observe a characteristic of an anatomy, and a sensor base coupled to the sensor. The medical device includes a coupling system to couple the sensor base to the anatomy. The coupling system includes a first adhesive member and a second adhesive member. The first adhesive member is coupled to the sensor base and the second adhesive member is to couple to the anatomy. The second adhesive member includes at least one cut-out to direct moisture to an ambient environment surrounding the medical device.
This invention pertains to systems and components useful for infusing medications such as insulin. Typically, the components are used to deliver insulin to a diabetic patient at a site of infusion over a period of time greater than 4 days. The system components typically comprise a cannula adapted for subcutaneous insertion into a diabetic patient. The system further comprises a fluid conduit adapted to deliver the insulin solution from a medication reservoir to the site of infusion and a depot in operable contact with the fluid conduit. The depot comprises selected materials including a site-loss mitigating agent (such as heparin) which inhibits inflammation at the site of infusion, and encapsulation of the cannula at the site of infusion. The site-loss mitigating agent is not premixed with the insulin, and instead is adapted to contact the insulin solution in the depot as the insulin solution flows from the medication reservoir to the site of infusion.
A61M 5/38 - Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular wayAccessories therefor, e.g. filling or cleaning devices, arm rests with means for eliminating or preventing injection or infusion of air into body using hydrophilic or hydrophobic filters
An insertion set system includes a base configured to be secured to a patient, and a flexible tubing on the base. The flexible tubing has a distal end portion forming a cannula to be inserted into the patient. An inserter having a needle is received by the base. The needle has a channel in which the distal end portion of the flexible tubing is received. The needle is able to slide relative to the flexible tubing, to selectively withdraw the needle off of the distal end portion of the flexible tubing. The base may include a passage for fluid flow arranged transverse to the axial dimension of the distal end portion of the flexible tubing.
Techniques for monitoring a physiological condition of a patient are provided. In some embodiments, the techniques may involve obtaining a predictive association model associated with the patient, wherein the predictive association model comprises an association of two or more categorical state values that are predictive of the patient consuming a meal. The techniques may further involve obtaining real-time data associated with the patient. The techniques may further involve determining a current state of the patient based at least in part on the real-time data by transforming the real-time data into two or more current state categorical values. The techniques may further involve predicting consumption of a meal in response to determining the two or more current state categorical values match the two or more categorical state values of the association.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
09 - Scientific and electric apparatus and instruments
Goods & Services
Downloadable mobile applications used to measure, collect, transmit, monitor, track and analyze diabetes information and diabetes patient data; downloadable mobile applications used to operate, monitor and manage diabetes medical devices, insulin pumps and glucose monitors; downloadable mobile applications used for the monitoring and treatment of diabetes; downloadable computer application software for mobile devices, namely, software for accessing a diabetes patient's medical and physiological data
Disclosed herein are techniques related to making trend based adjustments to insulin dosage. In some embodiments, the techniques may involve obtaining, based on glucose measurements performed on a person, a glucose value and a glucose rate of change (ROC). An initial insulin amount to deliver to the person is calculated based on this glucose value. However, an adjustment value can be obtained in response to a determination that the glucose value exceeds a glucose threshold, and that the glucose ROC exceeds an ROC threshold. The adjustment value represents an adjustment to be applied to the initial insulin amount when the glucose threshold and the ROC threshold are both exceeded. The adjustment value can be predetermined, based on earlier glucose measurements performed on the person. For instance, the adjustment value and the thresholds can be jointly determined through a computer simulation using a person-specific physiological model.
Infusion devices, systems, and related operating methods are provided. A method of detecting an anomalous condition with respect to a fluid path involves providing energy to an actuation arrangement to produce actuation, wherein the actuation arrangement is coupled to a plunger configured to deliver fluid via the fluid path, monitoring an orientation of the actuation arrangement using a sensing arrangement, and detecting an anomalous condition based on the orientation of the actuation arrangement.
A simple, disposable sensing device for sensing an analyte is housed in a single case. The sensing device can transmit sensor data to monitoring device(s). The sensing device includes: a case having a lower major wall adapted to be mounted against a patient's skin, and an upper opposing major wall; a sensor extending from the case and having a distal end sensitive to the analyte to produce an electrical signal, and a proximal end within the case having electrical contacts; a printed circuit board assembly within the case supported by one of the major walls to receive the electrical signal via the electrical contacts; and an elastomeric pad disposed in the case and biased by the other major wall to urge the proximal end of the sensor into contact with the printed circuit board assembly and maintain an electrical connection between the electrical contacts and the printed circuit board assembly.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
Techniques for automatic network configuration based on biometric authentication are described herein. In some embodiments, the techniques may involve obtaining first biometric data from a first device that is substantially attachable to or substantially worn on a body of a user. The techniques may further involve obtaining second biometric data from a second device that is substantially attachable to or substantially worn on the body of the user. The techniques may further involve comparing the first biometric data and the second biometric data. The techniques may further involve determining that the first biometric data and the second biometric data correspond to the same user based on the comparison. The techniques may further involve establishing a communication link with the second device based on the determination that the second device is attached to the body of the user.
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
A61M 5/172 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters electrical or electronic
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
H02J 7/00 - Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
H02J 7/02 - Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries for charging batteries from AC mains by converters
H04W 4/80 - Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication
Disclosed herein are techniques related to predicting a physiological condition of a user. In some embodiments, the techniques may involve obtaining one or more glucose concentration values measured from a user; applying, to the one or more glucose concentration values measured from the user, a first glucose prediction model for a first prediction horizon; obtaining, based on applying the first glucose prediction model, a first predicted glucose value of the user; and predicting a second predicted glucose value of the user for a second prediction horizon that is less than the first prediction horizon, based on the first predicted glucose value and at least one glucose concentration value of the one or more glucose concentration values. In some scenarios, the physiological condition may include, for example, hypoglycemia or hyperglycemia.
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
86.
MICRO MODELS AND LAYERED PREDICTION MODELS FOR ESTIMATING SENSOR GLUCOSE VALUES AND REDUCING SENSOR GLUCOSE SIGNAL BLANKING
Methods, systems, and devices for improving continuous glucose monitoring (“CGM”) are described herein. More particularly, the methods, systems, and devices describe applying micro machine learning models to generate predicted sensor glucose values. The system may use the predicted sensor glucose values to display a sensor glucose value to a user. The layered models may generate more reliable sensor glucose predictions across many scenarios, leading to a reduction of sensor glucose signal blanking. The methods, systems, and devices described herein further comprise applying a plurality of micro model to estimate sensor glucose values under outlier conditions. The system may prioritize the models that are trained for certain outlier conditions when the system detects those outlier condition based on the sensor data.
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
G16H 50/20 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
G16H 50/30 - ICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indicesICT specially adapted for medical diagnosis, medical simulation or medical data miningICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for individual health risk assessment
87.
INTELLIGENT MEDICATION DELIVERY SYSTEMS AND METHODS
Systems, devices, and techniques are disclosed for administering and tracking medicine to patients and providing health management capabilities for patients and caregivers. In some aspects, a system includes an injection pen device including a dose setting mechanism, a dispensing mechanism, and an electronics unit to generate dose data associated with a dispensing event of a dose of the medicine dispensed from the injection pen device and time data associated with the dispensing event; a mobile device in wireless communication to receive and process the dose data; and a software application configured to determine a recommended dose based on health data and contextual data associated with a user of the injection pen device, the software application including a learning dose calculator module to adaptively calculate the recommended dose of the medicine based on time-relevant and circumstances-relevant data specific to the user of the injection pen device.
A61M 5/32 - NeedlesDetails of needles pertaining to their connection with syringe or hubAccessories for bringing the needle into, or holding the needle on, the bodyDevices for protection of needles
A61M 5/34 - Constructions for connecting the needle
G01D 5/244 - Mechanical means for transferring the output of a sensing memberMeans for converting the output of a sensing member to another variable where the form or nature of the sensing member does not constrain the means for convertingTransducers not specially adapted for a specific variable using electric or magnetic means influencing characteristics of pulses or pulse trainsMechanical means for transferring the output of a sensing memberMeans for converting the output of a sensing member to another variable where the form or nature of the sensing member does not constrain the means for convertingTransducers not specially adapted for a specific variable using electric or magnetic means generating pulses or pulse trains
G01D 5/347 - Mechanical means for transferring the output of a sensing memberMeans for converting the output of a sensing member to another variable where the form or nature of the sensing member does not constrain the means for convertingTransducers not specially adapted for a specific variable using optical means, i.e. using infrared, visible or ultraviolet light with attenuation or whole or partial obturation of beams of light the beams of light being detected by photocells using displacement encoding scales
Medical devices used for the treatment of diabetes; medical apparatus for diabetes, namely, blood glucose monitors; medical equipment, namely, instruments and sensors for measuring blood glucose levels and instruments and sensors for diabetes monitoring; infusion apparatus for therapeutic purposes; injection device for pharmaceuticals; medical test kits for diabetes monitoring for home use; medical apparatus and equipment for use in electronic acquisition, capture, processing, presentation, storage and transmission of patient's medical and physiological data for use in programming, monitoring and operating medical devices used for the treatment and management of diabetes.
Medical devices used for the treatment of diabetes; medical apparatus for diabetes, namely, blood glucose monitors; medical equipment, namely, instruments and sensors for measuring blood glucose levels and instruments and sensors for diabetes monitoring; infusion apparatus for therapeutic purposes; injection device for pharmaceuticals; medical test kits for diabetes monitoring for home use; medical apparatus and equipment for use in electronic acquisition, capture, processing, presentation, storage and transmission of patient's medical and physiological data for use in programming, monitoring and operating medical devices used for the treatment and management of diabetes.
90.
ERROR HANDLING IN INFUSION DEVICES WITH DISTRIBUTED MOTOR CONTROL AND RELATED OPERATING METHODS
Techniques disclosed herein relate to operating a motor using a first control module and a second control module. The techniques may involve detecting, by the first control module, after loading application code for execution by the first control module and the second control module, an anomalous condition. The techniques may further involve in response to detection of the anomalous condition, disabling, by the first control module, input power to the motor. The techniques may further involve resetting the first control module and the second control module to a boot loader stage.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
A61M 5/145 - Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. by means of pistons
A61M 5/168 - Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters
G16H 40/63 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
91.
Nutritional content determination based on gesture detection data
Techniques disclosed herein relate to nutritional content determination based on gesture detection data. In some embodiments, the techniques involve obtaining gesture detection data corresponding to consumption of a food item or a drink; determining, based on the gesture detection data, nutritional content of the food item or the drink; and causing delivery of insulin in accordance with the nutritional content of the food item or the drink.
G16H 10/60 - ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
H04W 4/80 - Services using short range communication, e.g. near-field communication [NFC], radio-frequency identification [RFID] or low energy communication
92.
DETERMINATION OF ADJUSTMENTS TO FLUID DELIVERY SETTINGS
Infusion systems, infusion devices, and related operating methods are provided. In one example, a computer-implemented method includes identifying, based on an input meal size category of a meal event and a plurality of groups of historical meal events associated with a plurality of meal size categories for a person, a group of historical meal events having an associated meal size category that corresponds to the input meal size category, determining at least one person-specific variable representative of historical meal events in the identified group of historical meal events, determining a bolus insulin dosage based at least in part on the at least one person-specific variable, and causing administration of insulin to the person based on the bolus insulin dosage.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
The disclosed techniques include applying one or more voltage pulses to a working electrode of a sensor probe. The techniques may also involve measuring, using a current sensor, a set of one or more current responses corresponding to the applied one or more voltage pulses, wherein the set of one or more current responses form a quasi-Cottrell profile that approximates a portion of a Cottrell curve. The techniques may further involve comparing a characteristic of the quasi-Cottrell profile to sets of predetermined Cottrell profiles. The techniques may further involve calibrating the current sensor based on the comparison.
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61B 5/1495 - Calibrating or testing in vivo probes
G01N 33/49 - Physical analysis of biological material of liquid biological material blood
The present technology includes, for example, an insertion assembly comprising a frame including a tubular sidewall defining an internal cavity and a slot extending longitudinally along a portion of the sidewall. The insertion assembly further comprises a medical device configured to be inserted into the user's skin and a carrier carrying the medical device and at least partially disposed within the internal cavity of the frame. The carrier can be axially movable within the frame from a first, cocked position to a second extended position proximate. The carrier can include a protrusion disposed within the slot of the frame and configured to slide within the slot when the carrier moves axially within the frame. A ratio of a height of the protrusion to a width of the protrusion is greater than 1.
The present technology includes, for example, a seal assembly for a medicament infusion device. The seal assembly can comprise an annular dock seal comprising an upper surface, a lower surface, a radially inner surface, a radially outer surface, and a through-hole extending between the radially outer and inner surfaces and defining a first fluid flow path. The seal assembly can comprise a seal housing at least partially surrounding the dock seal and having an upper flange, a lower flange, a side portion configured to contact at least a portion of the radially outer surface of the dock seal to define an annular channel between the side portion of the seal housing and the radially outer surface of the dock seal, and a second fluid flow path extending through the side portion such that the second fluid flow path is in fluid communication with the first fluid flow path.
A flexible tubing for a cannula has a hollow tubing body having a length dimension from a first end to a second end, and an outer diameter of no more than 0.9 mm. The tubing body has a section of enhanced flexibility of a greater flexibility than one or more other sections of the tubing body. The section of enhanced flexibility is spaced from the first end of the tubing body by a distance D, where D is within a range of 3.0 mm to 5.0 mm for a flexible tubing having a length of about 9.0 mm, and where D is within a range of 1.0 mm to 2.9 mm for a flexible tubing having a length of about 6.0 mm.
Techniques for automatically configuring a medical device with user-specific configuration data are provided. In some embodiments, the techniques may involve determining, by a first medical device, that the first medical device is being removed from service on a patient based at least in part on detecting removal of a portion of the first medical device from contact with or being coupled to the patient. The techniques may further involve in response to determining that the first medical device is being removed from service on the patient, communicating user-specific configuration data used by the first medical device to a second medical device, wherein the second medical device is a replacement medical device for the first medical device.
G16H 20/17 - ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
G16H 40/60 - ICT specially adapted for the management or administration of healthcare resources or facilitiesICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
98.
USE OF ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY (EIS) IN GROSS FAILURE ANALYSIS
Electrochemical Impedance Spectroscopy (EIS) is used in conjunction with continuous glucose monitors and continuous glucose monitoring (CGM) to enable in-vivo sensor calibration, gross (sensor) failure analysis, and intelligent sensor diagnostics and fault detection. An equivalent circuit model is defined, and circuit elements are used to characterize sensor behavior.
A61B 5/0537 - Measuring body composition by impedance, e.g. tissue hydration or fat content
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/0538 - Measuring electrical impedance or conductance of a portion of the body invasively, e.g. using a catheter
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1468 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
A61B 5/1495 - Calibrating or testing in vivo probes
A continuous glucose monitoring system may utilize electrode current (Isig) signals, Electrochemical Impedance Spectroscopy (EIS), and Vcntr values to optimize sensor glucose (SG) calculation in such a way as to enable reduction of the need for blood glucose (BG) calibration requests from users.
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1468 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means
This disclosure generally relates to medical devices that include a transmitter assembly positioned on top of a sensor assembly. A sensor assembly includes a sensor base having a bottom surface and a top surface having an interface. The interface accommodates a sensor stack that includes at least one sensor head having electrical contact pads connected to an elastomeric connector. The sensor assembly further includes a mounting base having a first side that attaches to the bottom surface of the sensor base, and a second side that adheres to a patient's skin. A transmitter assembly includes a transmitter shell and a transmitter cap having an interface that engages with the sensor base. Also, the transmitter assembly includes electrical contacts disposed on the transmitter cap that connect with the electrical contact pad(s) of the sensor assembly.
A61B 5/00 - Measuring for diagnostic purposes Identification of persons
A61B 5/145 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value
A61B 5/1473 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
A61B 5/1486 - Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
